Ceramide enhances growth hormone (GH)-releasing hormone-stimulated cyclic adenosine 3',5'-monophosphate accumulation but inhibits GH release in rat anterior pituitary cells.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.140.12.5691PMID 10579333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Sphingomyelin Cycle and the Second Messenger Function of Ceramide "

  2001cited by this paper
• Ceramide selectively inhibits calcium-mediated potentiation of beta-adrenergic-stimulated cyclic nucleotide accumulation in rat pinealocytes.

  1998cited by this paper
• The role of ceramide in cell signaling.

  1998cited by this paper
• Sphingosine Inhibits Voltage-operated Calcium Channels in GH4C1 Cells*

  1998cited by this paper
• Involvement of ceramide in inhibitory effect of IL-1 beta on L-type Ca2+ current in adult rat ventricular myocytes.

  1997cited by this paper
• Elevation of Ceramide within Distal Neurites Inhibits Neurite Growth in Cultured Rat Sympathetic Neurons*

  1997cited by this paper
• Tyrosine kinase inhibitors enhance GHRH-stimulated cAMP accumulation and GH release in rat anterior pituitary cells.

  1997cited by this paper
• The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle.

  1996cited by this paper
• Ceramide Inactivates Cellular Protein Kinase Cα*

  1996cited by this paper
• Sphingolipid-gated Ca2+ Release from Intracellular Stores of Endothelial Cells Is Mediated by a Novel Ca2+-permeable Channel (*)

  1995cited by this paper
• Sphingosine derivatives inhibit depolarization-evoked calcium entry in rat GH4C1 cells.

  1995cited by this paper
• Endotoxin-induced suppression of the somatotropic axis is mediated by interleukin-1 beta and corticotropin-releasing factor in the juvenile rat.

  1995cited by this paper
• Control of cardiac Ca2+ levels. Inhibitory actions of sphingosine on Ca2+ transients and L-type Ca2+ channel conductance.

  1994cited by this paper
• The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling.

  1994cited by this paper
• Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms.

  1994cited by this paper
• The sphingomyelin cycle and the second messenger function of ceramide.

  1994cited by this paper
• Actions of growth-hormone-releasing hormone on rat pituitary cells: intracellular calcium and ionic currents

  1994cited by this paper
• Mechanisms of action of a second generation growth hormone-releasing peptide (Ala-His-D-beta Nal-Ala-Trp-D-Phe-Lys-NH2) in rat anterior pituitary cells.

  1993cited by this paper
• Stimulation and Inhibition of Growth Hormone Secretion by Interleukin-1β; The Involvement of Growth Hormone-Releasing Hormone

  1992cited by this paper
• Intracellular pH and growth hormone-releasing factor-stimulated adenosine 3'5'-monophosphate, intracellular calcium and growth hormone release from rat anterior pituitary cells.

  1992cited by this paper
• Stimulation and inhibition of growth hormone secretion by interleukin-1 beta: the involvement of growth hormone-releasing hormone.

  1992cited by this paper
• Free intracellular Ca2+ concentration and growth hormone (GH) release from purified rat somatotrophs. III. Mechanism of action of GH-releasing factor and somatostatin.

  1991cited by this paper
• Free intracellular Ca2+ concentration ([Ca2+]i) and growth hormone release from purified rat somatotrophs. I. GH-releasing factor-induced Ca2+ influx raises [Ca2+]i.

  1991cited by this paper
• Growth hormone-releasing factor does not activate protein kinase C in somatotrophs.

  1991cited by this paper
• Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation.

  1991cited by this paper
• Evidence for a role of protein kinase-C in His-D-Trp-Ala-Trp-D-Phe-Lys-NH2-induced growth hormone release from rat primary pituitary cells.

  1991influential reference
• Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin.

  1988cited by this paper
• Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebroside synthetase.

  1987cited by this paper
• Central action of interleukin‐1 in altering the release of tsh, growth hormone, and prolactin in the male rat

  1987cited by this paper
• Cyclic adenosine nucleotides and growth hormone-releasing factor increase cytosolic growth hormone messenger RNA levels in cultured rat pituitary cells.

  1986cited by this paper
• Protein kinase C enhances growth hormone releasing factor (1-40)-stimulated cyclic AMP levels in anterior pituitary. Actions of somatostatin and pertussis toxin.

  1986cited by this paper
• Growth hormone-releasing hormone.

  1986cited by this paper
• Growth hormone releasing hormone.

  1986cited by this paper
• Changes of free calcium levels with stages of the cell division cycle

  1985cited by this paper
• Modification of basal and GRF-stimulated cyclic AMP levels and growth hormone release by phospholipid metabolic enzyme inhibitors.

  1985cited by this paper
• Stimulation of adenosine 3',5'-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro.

  1983cited by this paper
• Altered release of growth hormone and thyrotropin induced by endotoxin in the rat.

  1982cited by this paper
• Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution.

  1975cited by this paper
• Culture of enzymatically dispersed pituitary cells: functional validation of a method.

  1972cited by this paper

• Local Hormones and Neurolipidomics in schizophrenia

  2023cites this paper
• A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.

  2019cites this paper
• ACTH-secreting Pancreatic Neoplasms Associated With Cushing Syndrome: Clinicopathologic Study of 11 Cases and Review of the Literature

  2015cites this paper
• Localization of Carboxyl Ester Lipase in Human Pituitary Gland and Pituitary Adenomas

  2010influential citation
• C2-ceramide inhibits the prostaglandin E2-induced accumulation of cAMP in human gingival fibroblasts.

  2010cites this paper
• Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.

  2008cites this paper
• Ceramide inhibits L-type calcium channel currents in GH3 cells.

  2004cites this paper
• Growth hormone-induced diacylglycerol and ceramide formation via Galpha i3 and Gbeta gamma in GH4 pituitary cells. Potentiation by dopamine-D2 receptor activation.

  2002cites this paper
• Gastrin and the neuropeptide PACAP evoke secretion from rat stomach histamine‐containing (ECL) cells by stimulating influx of Ca2+ through different Ca2+ channels

  2001cites this paper
• Ceramide inhibits the inwardly rectifying potassium current in GH(3) lactotrophs.

  2001cites this paper
• Inhibition of Sodium-Calcium Exchange by Ceramide and Sphingosine*

  2001cites this paper